Stock search

Ticker or company name

Labcorp

LH · NYSE · Health Care

$372,46Up +1,98 (+0,53%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$30,1 bn
Div. yield
1,4%
Year to date
+47,7%
52 weeks: $245,00$375,10

Ratio score

56/100
Ratio would watch

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

3 ✓ · 4 — · 2 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM30,025,325,1
Forward P/E18,6—16,2
PEG3,2—2,2
P/S2,11,62,2
EV/EBITDA19,817,917,3
P/FCF23,4—19,5
P/B3,42,43,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 27 analysts

Buy
21
Hold
6
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20264,804,78Down −0,3%
Q2 20264,924,99Up +1,4%
Q1 20264,214,25Up +1,0%
Q4 20254,064,07Up +0,3%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue3,81 bn3,73 bn3,54 bn3,52 bn3,56 bn3,53 bn3,35 bn3,33 bn3,28 bn3,22 bn3,18 bn3,03 bn
EPS3,223,643,351,983,122,842,521,712,002,432,69−1,86
Margin6,9%8,0%7,9%4,7%7,3%6,7%6,4%4,3%5,2%6,4%7,2%−5,5%
FCF412 m314 m70,5 m490 m281 m543 m−108 m665 m162 m433 m−164 m412 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $11,7 m.

NameAmountSharesPrice
caveney brian j10 Nov 2026 · sale$744 0802 000$372,04
vaughn bryan t3 Nov 2026 · sale$108 232306$353,70
parham richelle p30 Oct 2026 · sale$389 3951 078$361,22
anderson kerrii b17 Aug 2026 · sale$954 0603 000$318,02
schechter adam h11 Aug 2026 · sale$1,50 m4 669$320,37
summy amy b.4 Aug 2026 · sale$283 428924$306,74
wilkinson peter j3 Aug 2026 · sale$413 7511 338$309,23
wilkinson peter j3 Aug 2026 · sale$25 35682$309,22
vaughn bryan t2 Jul 2026 · sale$66 968234$286,19
kyle kathryn w2 Jul 2026 · sale$26 32992$286,19
kyle kathryn w8 Jun 2026 · sale$201 084762$263,89
schechter adam h11 May 2026 · sale$1,50 m5 903$254,50
meltzer jonathan c27 Mar 2026 · sale$224 055839$267,05
wilkinson peter j27 Mar 2026 · sale$436 0931 633$267,05
schechter adam h3 Mar 2026 · sale$2,44 m8 705$279,96

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
24 Apr 1991

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
DXCMDexcom$81,6189would consider31,4+13,0%19,4%
DGXQuest Diagnostics$262,2161would watch25,5+9,1%9,5%
RMDResMed$238,1983would consider21,3+9,0%27,8%
STESteris$261,9175would consider31,9+8,1%13,4%
CNCCentene Corporation$74,7772would consider24,2+9,7%0,7%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.